The survival rate of hepatocellular carcinoma in Asian countries: a systematic review and meta-analysis

Main Article Content

Soheil Hassanipour
Mouhebat Vali
Saber Gaffari-fam
Hossein-Ali Nikbakht
Elham Abdzadeh
Farahnaz Joukar
Akram Pourshams
Afshin Shafaghi
Mahdi Malakoutikhah
Morteza Arab-Zozani
Hamid Salehiniya
Fariborz Mansour-Ghanaei

Abstract

Hepatocellular carcinoma or Liver cancer (LC) is the sixth most common cancer and the fourth cause of death worldwide in 2018. There has not been a comprehensive study on the survival rate of patients with LC in Asia yet. Therefore, the present study was conducted to evaluate the survival rate of patients with LC in Asian countries. The methodology of the present study is based on the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) statement. The researchers searched five international databases including Medline/PubMed, Scopus, Embase, Web of Knowledge and ProQuest until July 1, 2018. We also searched Google Scholar for detecting grey literature. The Newcastle-Ottawa Quality Assessment Form was used to evaluate the quality of selected papers. A total of 1425 titles were retrieved. 63 studies met the inclusion criteria. Based on the random-effect model one-year, three-year and five-year survival rate of LC were 34.8 % (95 % CI; 30.3-39.3), 19 % (95 % CI ; 18.2-21.8) and 18.1 % (95 % CI ;16.1-20.1) respectively. According to the results of our study, the LC survival rate in Asian countries is relatively lower than in Europe and North America.

Article Details

How to Cite
Hassanipour, S., Vali, M., Gaffari-fam, S., Nikbakht, H.-A., Abdzadeh, E., Joukar, F., Pourshams, A., Shafaghi, A., Malakoutikhah, M., Arab-Zozani, M., Salehiniya, H., & Mansour-Ghanaei, F. (2020). The survival rate of hepatocellular carcinoma in Asian countries: a systematic review and meta-analysis. EXCLI Journal, 19, 108-130. https://doi.org/10.17179/excli2019-1842
Section
Review articles

Most read articles by the same author(s)